Vaccine

For active immunisation of cattle in the absence of maternally derived antibodies against: parainfluenza 3 virus, to reduce virus excretion due to infection bovine respiratory syncytial virus, to reduce virus excretion due to infection bovine viral diarrhoea virus, to reduce virus excretion due to infection Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset...

For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with Bovine Viral Diarrhoea virus.

For active immunisation of cattle to reduce infection, clinical signs and respiratory disease caused by Bovine Respiratory Synctial Virus (BRSV), Infectious Bovine Rhinotracheitis (IBR, caused by BHV-1) virus Parainfluenza type 3 Virus (PI3); and leucopenia and viraemia caused by the Bovine Viral Diarrhoea (BVD) virus Type 1 cytopathic and non-cytopathic strains. A duration of immunity...

For active immunisation of cattle to reduce the intensity and duration of clinical signs (pyrexia) induced by an infection with BHV-1 as well as to reduce the replication and nasal excretion of the field virus. Please note this is INACTIVATED, if you require Bovilis IBR Marker Live please click here.

For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

For the active immunisation of cattle against Infectious Bovine Rhinotracheitis (IBR) to reduce the clinical signs and virus shedding and, in female cattle, to prevent abortions associated with BHV-1 infection. The vaccination of pregnant cattle will prevent abortion associated with BHV-1 infection as demonstrated during the second trimester of gestation following challenge 28 days after vaccination. Duration...

For active immunisation of cattle in the absence of maternally derived antibodies against: parainfluenza 3 virus, to reduce virus excretion due to infection bovine respiratory syncytial virus, to reduce virus excretion due to infection Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity (demonstrated by challenge): 3 weeks after primary...

For the active immunisation of cattle against Parainfluenza3 virus (PI3 virus), to reduce infections. Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs. Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the...

To reduce the clinical signs and lung lesions caused by Mannheimia haemolytica serotype A1 and Histophilus somni in calves from 2 months of age.

Out of stock until mid-December. Please speak to your vet about alternatives.

For the active immunisation of cattle to reduce lesions and respiratory disease caused by Pasteurella haemolytica biotype A, serotype 1. Studies carried out show that a single dose is sufficient to confer protection from challenge by Pasteurella haemolytica within 7 days of vaccination. The vaccine will protect animals for at least 17 weeks.

For the active immunization of cattle from 1 month of age against Leptospira interrogans serovar hardjo and Leptospira borgpetersenii serovar hardjo. To reduce shedding of Leptospira interrogans serovar hardjo in urine. To improve herd fertility when infertility is diagnosed as caused by Leptospira hardjo. Circulating antibody is detectable 14 days following the first injection and persists...

For the active immunisation of pregnant cows and heifers to raise antibodies against E. coli adhesion F5 (K 99) antigen, rotavirus and coronavirus. When calves are fed colostrum from vaccinated cows during the first week of life, these antibodies have been demonstrated to reduce the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E. coli F5 (K99) and to...

Active immunisation of pregnant heifers and cows in order to stimulate the development of antibodies against bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin and to increase the level of passive immunity of calves against neonatal diarrhoea caused by bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin. In calves fed with colostrum and milk from...

Out of stock until November 2023.

For active immunisation of healthy cows and heifers to reduce the incidence of clinical intramammary infections caused by Streptococcus uberis, to reduce the somatic cell count in Streptococcus uberis positive quarter milk samples and to reduce milk production losses caused by Streptococcus uberis intramammary infections. Onset of immunity: approximately 36 days after the second dose. Duration...

Out of stock. Please speak to your vet for advice.

Out of stock with no due date. Please speak to your vets about alternatives.